OBJECTIVE: The objective of this study was to investigate the effect of intraoperative application of steroid suspension and coating of the electrode contacts with a thin film of iridium oxide on the short-term, time-dependent development of the intracochlear impedance in adults implanted with the Nucleus 24 Contour electrode. STUDY DESIGN: The time-dependent development of intracochlear impedances was investigated in four different groups of adult patients at daily and later weekly intervals until the first fitting. The four groups were as follows: 1) standard Nucleus 24 Contour (control, n = 7); 2) standard Nucleus 24 Contour with intraoperative application of steroids (Group S, n = 6); 3) iridium-coated Nucleus 24 Contour control (Group I, n = 8); and 4) iridium-coated Nucleus 24 Contour with intraoperative application of steroids (Group I + S, n = 5). All patients had postlinguistic onset of severe to profound sensorineural hearing loss and no or little benefit of conventional hearing aids. Absence of ossification or any other cochlear anomaly and also absence of signs of retrocochlear or central origin to the hearing impairment bilaterally had to be confirmed preoperatively. RESULTS: Steroid application reduced impedances significantly (Groups S and I + S), whereas iridium coating lowered variance of the impedance among patients but did not reduce the impedance significantly. The steroid-induced reduction is more pronounced at basal electrode contacts. Furthermore, there is some indication that the tissue growth could be faster in patients having the iridium-coated Contour electrode. CONCLUSION: Provided that the reduction of electrode impedances with application of steroids is persisting, intracochlear application of steroids can be considered on a regular basis. Iridium coating of the electrode contacts seems not to be justified to be included as standard procedure.
OBJECTIVE: The objective of this study was to investigate the effect of intraoperative application of steroid suspension and coating of the electrode contacts with a thin film of iridium oxide on the short-term, time-dependent development of the intracochlear impedance in adults implanted with the Nucleus 24 Contour electrode. STUDY DESIGN: The time-dependent development of intracochlear impedances was investigated in four different groups of adult patients at daily and later weekly intervals until the first fitting. The four groups were as follows: 1) standard Nucleus 24 Contour (control, n = 7); 2) standard Nucleus 24 Contour with intraoperative application of steroids (Group S, n = 6); 3) iridium-coated Nucleus 24 Contour control (Group I, n = 8); and 4) iridium-coated Nucleus 24 Contour with intraoperative application of steroids (Group I + S, n = 5). All patients had postlinguistic onset of severe to profound sensorineural hearing loss and no or little benefit of conventional hearing aids. Absence of ossification or any other cochlear anomaly and also absence of signs of retrocochlear or central origin to the hearing impairment bilaterally had to be confirmed preoperatively. RESULTS:Steroid application reduced impedances significantly (Groups S and I + S), whereas iridium coating lowered variance of the impedance among patients but did not reduce the impedance significantly. The steroid-induced reduction is more pronounced at basal electrode contacts. Furthermore, there is some indication that the tissue growth could be faster in patients having the iridium-coated Contour electrode. CONCLUSION: Provided that the reduction of electrode impedances with application of steroids is persisting, intracochlear application of steroids can be considered on a regular basis. Iridium coating of the electrode contacts seems not to be justified to be included as standard procedure.
Authors: Anne Bohl; Henning W Rohm; Piera Ceschi; Gerrit Paasche; Anne Hahn; Stephan Barcikowski; Thomas Lenarz; Timo Stöver; Hans-Wilhelm Pau; Klaus-Peter Schmitz; Katrin Sternberg Journal: J Mater Sci Mater Med Date: 2012-06-17 Impact factor: 3.896
Authors: Aarno Dietz; Minna Wennström; Antti Lehtimäki; Heikki Löppönen; Hannu Valtonen Journal: Eur Arch Otorhinolaryngol Date: 2015-07-12 Impact factor: 2.503
Authors: Gentiana I Wenzel; Petra Sarnes; Athanasia Warnecke; Timo Stöver; Burkard Jäger; Anke Lesinski-Schiedat; Thomas Lenarz Journal: Eur Arch Otorhinolaryngol Date: 2014-12-06 Impact factor: 2.503
Authors: Nils K Prenzler; Rolf Salcher; Max Timm; Lutz Gaertner; Thomas Lenarz; Athanasia Warnecke Journal: Drug Deliv Transl Res Date: 2018-10 Impact factor: 4.617
Authors: Erin E Leary Swan; Mark J Mescher; William F Sewell; Sarah L Tao; Jeffrey T Borenstein Journal: Adv Drug Deliv Rev Date: 2008-09-21 Impact factor: 15.470
Authors: Mareike Hütten; Anandhan Dhanasingh; Roland Hessler; Timo Stöver; Karl-Heinz Esser; Martin Möller; Thomas Lenarz; Claude Jolly; Jürgen Groll; Verena Scheper Journal: PLoS One Date: 2014-08-08 Impact factor: 3.240